Literature DB >> 20105644

Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure.

Jason S Soden1, Mark A Lovell, Kristin Brown, David A Partrick, Ronald J Sokol.   

Abstract

Parenteral omega-3 fatty acid lipid emulsions have been evaluated for their potential role in reversing intestinal failure-associated liver disease. We report our experience using Omegaven in 2 patients with irreversible intestinal failure and intestinal failure-associated liver disease. Despite biochemical and histologic improvement in cholestasis, both patients had persisting, significant portal fibrosis on liver biopsy. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20105644     DOI： 10.1016/j.jpeds.2009.08.033

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  23 in total

1.  Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literature.

Authors:  Emma M Tillman; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

2.  Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.

Authors:  Caroline Wang; Robert S Venick; Stephen B Shew; James C Y Dunn; Laurie Reyen; Rong Gou; Kara L Calkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-11-08       Impact factor: 4.016

Review 3.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

Review 4.  Redefining short bowel syndrome in the 21st century.

Authors:  Valeria C Cohran; Joshua D Prozialeck; Conrad R Cole
Journal:  Pediatr Res       Date:  2016-12-20       Impact factor: 3.756

Review 5.  Medical update and potential advances in the treatment of pediatric intestinal failure.

Authors:  Nader N Youssef; Adam G Mezoff; Beth A Carter; Conrad R Cole
Journal:  Curr Gastroenterol Rep       Date:  2012-06

Review 6.  Approach to Intestinal Failure in Children.

Authors:  Danielle Wendel; Conrad R Cole; Valeria C Cohran
Journal:  Curr Gastroenterol Rep       Date:  2021-04-15

7.  Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

Authors:  Kara L Calkins; James C Y Dunn; Stephen B Shew; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert S Venick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-07-26       Impact factor: 4.016

8.  Prevention and treatment of intestinal failure-associated liver disease in children.

Authors:  Bram P Raphael; Christopher Duggan
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

9.  Enteral autonomy, cirrhosis, and long term transplant-free survival in pediatric intestinal failure patients.

Authors:  Brenna S Fullerton; Eric A Sparks; Amber M Hall; Christopher Duggan; Tom Jaksic; Biren P Modi
Journal:  J Pediatr Surg       Date:  2015-10-23       Impact factor: 2.545

10.  The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.

Authors:  Prathima Nandivada; Melissa I Chang; Alexis K Potemkin; Sarah J Carlson; Eileen Cowan; Alison A Oʼloughlin; Paul D Mitchell; Kathleen M Gura; Mark Puder
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.